All In MedTech

FDA Clearance Tracker · P920015-S164

SPRINT QUATTRO SECURE S MRI SURESCAN LEAD, SPRINT QUATTRO SECURE MRI SURESCAN LEAD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 19, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 19, 2016

Approved

Time to decision

111 days

Received Sep 30, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P920015-S164
Device name
SPRINT QUATTRO SECURE S MRI SURESCAN LEAD, SPRINT QUATTRO SECURE MRI SURESCAN LEAD
Applicant location
Mounds View, MN
Received
Sep 30, 2015
Decided
Jan 19, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P920015

Device type

Device class
Class III

Every decision under product code LWS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE VISIA AF AND VISIA AF MRI SINGLE-CHAMBER (VR) ICD DEVICES AND PROGRAMMER APPLICATION SOFTWARE MODEL SW035.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.